Stereotaxis, Inc. (Nasdaq:STXS) is stumbling 15% after the medical devices maker posted first-quarter revenue of $7 million, down 23% from $9.2 million a year earlier. Analysts anticipated $8 million in revenue. The St. Louis-based company’s quarterly net loss widened to $0.37 per share, versus Wall Street analysts’ estimate of losing $0.33 per share.

---You can read the FULL article when you register (registration is free!) or sign-in to SmallCapInvestor.com---